EMILEE LAM-STEVENS: Open Payments
NPI 1558920645 · RICHMOND, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 24 payments from 10 companies in 2025. Trend: 2023 $307 · 2024 $249 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $112 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| Lundbeck LLC | 3 | $56 |
| PFIZER INC. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Viatris Specialty LLC | 2 | $35 |
| Novo Nordisk Inc | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: VRAYLAR, FANAPT, REXULTI, AJOVY, YUPELRI, VYEPTI, NURTEC ODT, BOTOX.
Industry payments across MO — which companies pay providers there.
